First human test of experimental ALS injection begins
Disease control
Recruiting now
This early-stage study is testing the safety of a new drug called AMX0114 for people with ALS. The drug is given as an injection into the spinal fluid in the lower back. Researchers will monitor 48 adults with early-stage ALS to see how their bodies handle the treatment and check…
Phase: PHASE1 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC